EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Brassinin from Brassica campestris L. inhibits colorectal cancer by inducing p62/ NRF2 / GPX4 ‐regulated ferroptosis

Shi-Yuan Wen iD, Rui-Rui Gao, Yan-Yan Chen, Yi-Jie Wang, Xin-Tong Wang, Hai-Xin Liu

Animal Models and Experimental Medicine · 2025-07 · 8 (7) · 1155-1165

DOI: 10.1002/ame2.12521 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Animal Models and Experimental Medicine, online erschienen am 23.01.2025. Verfasst von Shi-Yuan Wen und 5 weiteren Autor:innen. Beteiligte Einrichtung: College of Basic Medical Sciences, Shanxi Medical University, Taiyuan, China. Hauptthemen laut MEDLINE: Ferroptosis, Colorectal Neoplasms, NF-E2-Related Factor 2, Brassica. Die Arbeit wurde bisher 13-mal zitiert (Crossref) und nennt 33 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Science and technology innovation ability cultivation program project of Shanxi University of Chinese Medicine, Natural Science Foundation of Shanxi Province for Youths, The immune regulation Chinese medicine research and development innovation team project.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Indole phytoalexins, plant‐derived compounds present in cruciferous vegetables, have demonstrated anticancer properties. Brassinin (BSN), derived from Brassica campestris L. var. campestris, is known for its potent antitumor effects on various cancers. However, the role of ferroptosis in regulating the antitumor effects of BSN has not been fully elucidated.

Methods

The components of B. campestris L. against colorectal cancer (CRC) were analyzed by network pharmacology. CCK‐8 assay and colony formation assay detected cell viability induced by BSN. Molecular docking verified the binding of BSN to the target protein. Western blot and reverse transcription–quantitative polymerase chain reaction (RT‐qPCR) assay revealed whether BSN can inactivate the NRF2 signaling and inhibit the expression of p62 and HO‐1. The RKO‐xenograft tumor models were established and then were treated by 75 or 150 mg/kg BSN to verify the antitumor efficacy and side effects of BSN.

Results

Network pharmacology suggested that BSN is the most important component of B. campestris L. against CRC. BSN inhibits CRC cell viability in a dose‐ and time‐dependent manner. Furthermore, this inhibitory effect is associated with the induction of ferroptosis, as BSN suppresses the cell viability of CRC by inducing GPX4‐regulated ferroptosis. BSN may bind to NRF2 protein to inactivate the NRF2 signaling, inhibiting the expression of p62 and HO‐1. Importantly, a low dose or a high dose of BSN significantly reduced the tumor growth in vivo.

Conclusions

Our findings reveal that BSN blocks CRC growth by inducing p62/NRF2/GPX4‐regulated ferroptosis, which may be a novel lead compound for tumor treatment.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

FerroptosisColorectal NeoplasmsNF-E2-Related Factor 2BrassicaPhospholipid Hydroperoxide Glutathione PeroxidaseIndolesThiocarbamatesHumansAnimalsCell Line, TumorMiceMice, Inbred BALB CSignal TransductionPhytoalexins

Stichwörter der Autor:innen

BrassininGPX4NRF2colorectal cancerferroptosis

Substanzen

NF-E2-Related Factor 2brassininPhospholipid Hydroperoxide Glutathione PeroxidaseIndolesThiocarbamatesNFE2L2 protein, humanPhytoalexins

Autor:innen und Institutionen

  • College of Basic Medical Sciences, Shanxi Medical University, Taiyuan, China.
  • College of Traditional Chinese Medicine and Food Engineering, Shanxi University of Chinese Medicine, Taiyuan, China.
  • School of Medicine, Jiangsu University, Zhenjiang, China.

ORCID-Profile: Shi-Yuan Wen

Förderung

  • Science and technology innovation ability cultivation program project of Shanxi University of Chinese Medicine
  • Natural Science Foundation of Shanxi Province for Youths
  • The immune regulation Chinese medicine research and development innovation team project
  • Science Research Start-up Fund for Doctor of Shanxi Medical University

Zitieren

APA

Wen, S. Y., Gao, R. R., Chen, Y. Y., Wang, Y. J., Wang, X. T., & Liu, H. X. (2025). Brassinin from Brassica campestris L. inhibits colorectal cancer by inducing p62/ NRF2 / GPX4 ‐regulated ferroptosis. Animal Models and Experimental Medicine, 8(7), 1155-1165. https://doi.org/10.1002/ame2.12521

Vancouver

Wen SY, Gao RR, Chen YY, Wang YJ, Wang XT, Liu HX. Brassinin from Brassica campestris L. inhibits colorectal cancer by inducing p62/ NRF2 / GPX4 ‐regulated ferroptosis. Animal Models and Experimental Medicine. 2025;8(7):1155-1165. doi:10.1002/ame2.12521

BibTeX
@article{Wen2025,
  author = {Wen, Shi-Yuan and Gao, Rui-Rui and Chen, Yan-Yan and Wang, Yi-Jie and Wang, Xin-Tong and Liu, Hai-Xin},
  title = {Brassinin from Brassica campestris L. inhibits colorectal cancer by inducing p62/ NRF2 / GPX4 ‐regulated ferroptosis},
  journal = {Animal Models and Experimental Medicine},
  year = {2025},
  volume = {8},
  number = {7},
  pages = {1155--1165},
  doi = {10.1002/ame2.12521}
}
Kostenlos starten →